A Randomized, Double-blind, Placebo-controlled Study to Demonstrate the Efficacy of Xolair in an Allergen Bronchoprovocation Study in Asthmatic Populations Defined by Serum IgE Concentrations.
Phase of Trial: Phase IV
Latest Information Update: 25 Nov 2014
At a glance
- Drugs Omalizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Novartis
- 11 Feb 2011 Trial phase changed from II to IV as reported by ClinicalTrials.gov.
- 11 Feb 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Feb 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.